Biodexa Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)
Biodexa Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Biodexa Pharmaceuticals | 424B3: Prospectus
Biodexa Pharmaceuticals | 424B3: Prospectus
Biodexa Pharmaceuticals | 424B3: Prospectus
Biodexa Pharmaceuticals | EFFECT: Others
Biodexa Pharmaceuticals | EFFECT: Others
Biodexa Pharmaceuticals | EFFECT: Others
Biodexa Pharmaceuticals | EFFECT: Others
Biodexa Pharmaceuticals | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Biodexa Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Biodexa Pharmaceuticals | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Biodexa Pharmaceuticals | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Biodexa Pharmaceuticals | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Biodexa Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Biodexa Pharmaceuticals | 20-F: Registration statement / Annual report / Transition report
Biodexa Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)
Biodexa Pharmaceuticals | EFFECT: Others
Biodexa Pharmaceuticals | 424B3: Prospectus
Biodexa Pharmaceuticals | CORRESP: CORRESP
No Data